Evidence map›Paper›PMID 33007284›Full record

ArticleThe Lancet. Respiratory medicine2020

A threat to decentralised care for drug-resistant tuberculosis.

Adam T Gray, Tom Boyles, Susanne Luedtke, Bianca Sossen, Georgiana Birjovanu, Patty Kostkova, Jennifer Hughes, Hanif Esmail

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Lancet. Respiratory medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Adam T GrayDepartment of Infectious Diseases, Imperial College Healthcare NHS Trust, London, UK.
Tom BoylesUniversity of Witwatersrand, Johannesburg, South Africa; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.
Susanne LuedtkeInstitute for Risk and Disaster Reduction, Centre for Digital Public Health in Emergencies, University College London, London, UK.
Bianca SossenWellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Georgiana BirjovanuInstitute for Risk and Disaster Reduction, Centre for Digital Public Health in Emergencies, University College London, London, UK.
Patty KostkovaInstitute for Risk and Disaster Reduction, Centre for Digital Public Health in Emergencies, University College London, London, UK.
Jennifer HughesDesmond Tutu TB Centre, Department of Paediatrics and Child Health, University of Stellenbosch, Cape Town, South Africa.
Hanif EsmailInstitute for Global Health, University College London, London, UK; Medical Research Council Clinical Trials Unit, University College London, London, UK; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa. Electronic address: h.esmail@ucl.ac.uk.

Funding

Medical Research Council MC_UU_12023/27
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antitubercular AgentsDrug Administration ScheduleHumansPatient-Centered CareTuberculosis, Multidrug-ResistantAntitubercular Agents

Identifiers

PMID33007284
PMCPMC7524514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.